icon bookmark-bicon bookmarkicon cameraicon checkicon chevron downicon chevron lefticon chevron righticon chevron upicon closeicon v-compressicon downloadicon editicon v-expandicon fbicon fileicon filtericon flag ruicon full chevron downicon full chevron lefticon full chevron righticon full chevron upicon gpicon insicon mailicon moveicon-musicicon mutedicon nomutedicon okicon v-pauseicon v-playicon searchicon shareicon sign inicon sign upicon stepbackicon stepforicon swipe downicon tagicon tagsicon tgicon trashicon twicon vkicon yticon wticon fm
11 May, 2021 08:21

EU launches second legal action against AstraZeneca for underdelivering on Covid-19 shots

EU launches second legal action against AstraZeneca for underdelivering on Covid-19 shots

The European Commission has brought a second legal case against AstraZeneca in the ongoing dispute over the supply of lifesaving Covid-19 jabs. Those familiar with the matter describe the new case as procedural.

European officials told Reuters that the new legal action, launched on Tuesday by the European Commission, concerned the merits of the case against AstraZeneca and would allow the European Union to pursue financial penalties. 

Yesterday, a spokesman for the European Commission said “the merits [of the proposed lawsuit] will be introduced before the Belgian court,” today. 

The first legal case, launched in April, concerned requesting faster delivery of AstraZeneca’s Covid-19 jab. The European Commission accused the company of a “breach” of the advance purchase agreement on Covid-19 vaccines it signed with the EU. 

Also on rt.com AstraZeneca boss says ‘we never overpromised’ on Covid-19 jab, asks people to imagine situation without Anglo-Swedish shot

According to EU supply data, the Anglo-Swedish firm delivered its 50-millionth shot to the bloc on Monday – far below its contractual promise. The company’s contract with the EU said it would commit its “best reasonable efforts” to deliver 300 million doses by the end of June. 

Both the company and its vaccine have been heavily criticized by EU lawmakers, with one likening AstraZeneca to an “unreliable second-hand car salesman.” The bloc’s regulator has raised concerns about rare cases of blood clots linked to the vaccine, leading to several limits being introduced on its administration by national governments.

AstraZeneca has dismissed the EU’s criticism, saying it has done everything it could to deliver as many shots to the EU as possible. “We never overpromised. We communicated what we thought we would achieve at the time,” CEO Pascal Soriot told a media briefing in April. 

If you like this story, share it with a friend!